Dorsal Root Ganglion Stimulation for Spinal Cord Injury

This trial tests a new treatment using a device to stimulate nerves near the spine. It targets individuals with spinal cord injuries below the tenth thoracic vertebra. The goal is to determine if this treatment can improve muscle movement and function in the legs. Individuals who sustained a spinal cord injury over a year ago and still have some muscle reflexes might be suitable candidates. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance future treatment options.

The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the research team to understand any specific requirements.

Studies have shown that stimulating the dorsal root ganglion (DRG) safely treats chronic pain. Research suggests that DRG stimulation's safety is comparable to spinal cord stimulation, with similar risks such as device movement or breakage.

In several studies, patients experienced positive outcomes with DRG stimulation, with over a third reporting significant pain reduction after 12 months. Although the device might need removal over time, DRG stimulation is generally considered safe and effective.

Dorsal Root Ganglion Stimulation is unique because it targets the nerve clusters directly involved in transmitting pain and sensory signals—something current standard treatments, like physical rehabilitation and medication, don't specifically do. This neurostimulator works by sending electrical impulses to the dorsal root ganglion, potentially offering more precise pain and sensory control for spinal cord injury patients. Researchers are excited because this approach could provide improved sensation and pain relief, possibly enhancing quality of life for individuals with injuries below the T10 vertebra, where traditional methods may fall short.

Research has shown that the Abbott Dorsal Root Ganglion (DRG) Stimulator can help reduce pain. Studies found that over 80% of patients experienced significant pain reduction, with levels dropping to as low as 1.7 in some cases. This treatment is particularly effective for long-term nerve pain, which results from nerve damage. Reports indicate that DRG stimulation improves quality of life more effectively than traditional spinal cord stimulation methods. Additionally, the treatment has demonstrated safety and effectiveness over extended periods. In this trial, researchers will treat one adult patient with a spinal cord injury below T10 using DRG stimulation. While most current data focuses on pain relief, these findings suggest potential benefits for issues related to spinal cord injuries.³⁴⁶⁷⁸